Ground Swell Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Ground Swell Capital’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,477	Closed	-$489K	–	105
2023 Q1	$489K	Buy	+4,477	New	+$495K	0.82%	8
2022 Q2	–	Sell	-1,977	Closed	-$208K	–	197
2022 Q1	$208K	Buy	+1,977	New	+$193K	0.53%	39
2014 Q3	$43K	Buy	+3,505	New	+$40.7K	0.08%	257

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ground Swell Capital's HZNP Position: Q2 2023 in Review

Ground Swell Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 4,477 shares — an estimated $489K sold.

Ground Swell Capital first reported a position in HZNP in Q3 2014 and held it in 3 quarters. The position peaked at $489K in Q1 2023. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Ground Swell Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Ground Swell Capital sold 4,477 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $489K.
Ground Swell Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 3 quarters.
Ground Swell Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $489K in Q1 2023.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Ground Swell Capital's 13F filing for Q2 2023, filed 10 Aug 2023.